New Delhi-based Varco Leg Care, the world’s first dedicated leg care brand, has raised a cumulative of US$ 0.5 Million (over INR 4.5 Cr) in seed funding, while doubling its valuation within a span of only 10 months
Glenmark Pharmaceuticals is in the process of pulling back 6,528 bottles of medication used for high blood pressure treatment from the American market due to issues with dissolution specifications, PTI reported citing the US Food and Drug Administrat
Exports in the India's pharmaceutical sector to the US have surged 15% in the first 11 months of the financial year 2024 despite being faced with many regulatory challenges and rise in product pricing pressures.
SaniSure, a worldwide player in single-use bioprocessing items, has declared the launch of Fill4Sure, a custom single-use filling gathering intended to facilitate drugs to market and construct security, effectiveness and repeatability into your...
A nation's healthcare system is only as strong as its infrastructure. From well-equipped hospitals to specialized clinics, a robust network of facilities is essential for delivering quality healthcare to every citizen.
India's pharmaceutical exports to the USA increased by 15% in the first 11 months of the last monetary year despite administrative difficulties and rising estimating pressures. The speed of exports has dramatically increased from the 6.18%...
Harmony Biosciences, a dedicated firm in creating and conveying medicines for uncommon neurological sicknesses, has declared a licensing contract with Bioprojet to create, make and popularize TPM-1116, an exceptionally strong and specific oral...
Lamassu Bio Inc., a cutting-edge biotech organization, is pleased to report that its spearheading work to battle privately progressed metastatic p53 wild-type cancers has secured investigational new drug application (IND) endorsement from the US...
Swiss drugmaker Novartis AG has signed a licensing agreement with Arvinas worth up to $1.01 billion to acquire access to the U.S. biotech firm's experimental prostate cancer medication, Arvinas added. The agreement strengthens Novartis' pursuit...
Macomics Ltd, a biotechnology firm, has revealed information about its lead program, a first-in-class ligand independent-pan-LILRB monoclonal antibody for the treatment of cancer, having introduced key information on MACO-355 at the American...
, CDSCO.jpg)
